
|Articles|December 2, 2022
CRO Vial Highlights Clinical Trial Platform
Recent investments bring clinical trial technology platform to the fore.
Advertisement
Vial, a CRO that was founded in 2020, is growing awareness around its company with a recent influx of funding. Vial was formed with the goal of bringing professionals with clinical trial depth and expertise together with Silicon Valley experts to build a technology platform. This platform features three key areas of clinical trial conduct--site startup, eSource and patient recruitment—each in its own part of the platform.
For more information, please read the
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
2
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
3
ACT Brief: Neutral Tech Adoption at Sites, Scaling Unstructured Data for eSource, and Novo Nordisk’s CagriSema NDA
4
ACT Brief: Rethinking Site Support in 2026, GSK’s New Severe Asthma Approval, and Priority Review Momentum in Multiple Myeloma
5




